Transparency, reproducibility, and validation: Raising the quality of reporting at the journal of neuro-ophthalmology

Journal of Neuro-Ophthalmology

Volumn 35, Issue 1, 2015, Pages 3-5

  Roberts, Jason L ^a,b   Shamseer, Larissa ^c,d  

^a Ediial Off Journal of Neuro Ophthalmology   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AUTHOR; EDITORIAL; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; NEUROOPHTHALMOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY; VALIDATION PROCESS; NEUROLOGY; OPHTHALMOLOGY; PUBLISHING;

HUMANS; JOURNALISM, MEDICAL; NEUROLOGY; OPHTHALMOLOGY; REPRODUCIBILITY OF RESULTS;

EID: 84923668701     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0000000000000219     Document Type: Editorial

References (23)

1. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ. 2010;340:c723
2. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ. 2008;336:1472-1474
3. Pino C, Boutron I, Ravaud P. Inadequate description of educational interventions in ongoing randomized controlled trials. Trials. 2012;13:63
4. Shukralla AA, Tudur-Smith C, Powell GA, Williamson PR, Marson AG. Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms. Epilepsy Res. 2011;97:20-29
5. Carp J. The secret lives of experiments: methods reporting in the fMRI literature. Neuroimage. 2012;63:289-300
6. O'Day R, Walton R, Blennerhassett R, Gillies MC, Barthelmes D. Reporting of harms by randomised controlled trials in ophthalmology. Br J Ophthalmol. 2014;98:1003-1008
7. Eyawo O, Lee CW, Rachlis B, Mills EJ. Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature. Trials. 2008;9:69
8. Borg Debono V, Zhang S, Ye C, Paul J, Arya A, Hurlburt L, Murthy Y, Thabane L. The quality of reporting of RCTs used within a postoperative pain management meta-analysis, using the CONSORT statement. BMC Anesthesiol. 2012;12:13
9. Siddiqui MA, Azuara-Blanco A, Burr J. The quality of reporting of diagnostic accuracy studies published in ophthalmic journals. Br J Ophthalmol. 2005;89:261-265
10. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332
11. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340: c869
12. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; for the STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100
16. The CONSORT statement Website [Internet]. 2014. Available at: www.consort-statement.org. Accessed December 3, 2014
17. Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT statement impact the completeness of reporting of randomised controlled trials published in medical journals? A cochrane review. Syst Rev. 2012;1:60
18. Stevens A, Shamseer L, Weinstein E, Yazdi F, Turner L, Thielman J, et al. Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review. BMJ. 2014;348:g3804
19. Baskin PK, Gross RA. Publishing rigor: an extension of scientific rigor: Minding the business of scientific reporting. Neurology. 2014;83:2-3
20. American Journal of Ophthalmology Instructions for Authors [Internet]. Available at: http://www.ajo.com/content/authorinfo. Accessed December 3, 2014
21. Principles and guidelines for reporting preclinical research-about NIH-National Institutes of Health (NIH) [Internet]. Available at: http://www.nih.gov/about/reporting-preclinical-research.htm. Accessed December 3, 2014
22. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012;490:187-191
23. Roberts JL, Houle TH, Loder EW, Penzien DP, Turner DP, Rothrock JF. Establishing a coherent reporting guidelines policy in health journals. In: Moher D, Altman DG, Schulz KF, Simera I, Wager E, eds. Guidelines for Reporting Health Research. Chichester, United Kingdom: Wiley-Blackwell, 2014:309-317.